One North Carolina Small Business Program

The One North Carolina Small Business Program is comprised of two programs:

  • The SBIR/STTR Phase I Incentive Funds Program.
  • The SBIR/STTR Phase I Matching Funds Program.

As authorized by North Carolina General Statute § 143B‑437.80 the SBIR/STTR Phase I Incentive Funds Program provides reimbursement to qualified North Carolina businesses for a portion of the costs incurred in preparing and submitting Phase I SBIR or STTR proposals to federal agencies. This program is currently inactive.

As authorized by North Carolina General Statute § 143B‑437.81 the SBIR/STTR Phase I Matching Funds Program awards matching funds to North Carolina businesses who have received a federal Phase I Small Business Innovation Research (SBIR) Program or Small Business Technology Transfer (STTR) award. This program is currently active for North Carolina’s 2019 fiscal year (July 1, 2018 – June 30, 2019).

To learn about the impacts of this program, see Grant Program Impacts and the latest press release (8/21/2017).

The One North Carolina Small Business Program is administered by the Office of Science, Technology & Innovation on behalf of the Board of Science, Technology & Innovation.

Apply to Program

Apply to Program

The One North Carolina Small Business Matching Funds Program is currently open for North Carolina’s 2019 fiscal year (July 1, 2018 – June 30, 2019).

Prior to submitting your application, please review the current (FY 2019) solicitation for more information about the program.

Applications, as well grant and reporting requirements, are managed through the sciGrants Management System.

To begin your application for the FY 2019 One North Carolina Small Business Matching Funds Program, click here.

If you have a problem related to your application (for example: requesting a DUNS number, uploading files, etc.), please email the Office of Science, Technology & Innovation.

Solicitation & Guidelines

Solicitation & Guidelines

NEW: Updated 9/14/2018

FY 2019 Solicitation: Funding Available

Access the FY 2019 solicitation here.

Under the current (FY 2019) solicitation, the maximum grant award is 50% of the Federal SBIR/STTR Program award, not to exceed $50,000. The current solicitation period is July 1, 2018 - June 30, 2019 inclusive, or until funds have been exhausted. Due to funding limitations this year, eligible applicants are limited to only those Phase I SBIR/STTR awardees that meet either of the following two conditions:

  1. Have not previously received a matching award under the One North Carolina Small Business Program and have less than 10 employees, or
  2. Are located in a Tier 1 or 2 county (2018 designations), as defined by the NC Department of Commerce.

Applicants must have received official notification of Phase I award by a federal SBIR/STTR agency during the solicitation period (July 1, 2018 - June 30, 2019 inclusive) to be eligible. Applications must be submitted within 45 days of receipt of an applicant's federal award notification. For companies whose federal notification occurred between the start date (July 1, 2018) and release date (September 14, 2018) of the solicitation, applications must be received within 45 days from the release date of the solicitation.

For additional eligibility requirements, please see the current solicitation above or the Program Guidelines.

If you have questions, please contact the OSTI staff.

Program History

Program History

The One North Carolina Small Business Program helps small businesses develop and commercialize innovative technologies to benefit the general population. In the process, it helps high-tech businesses attract more funding to the state―keeping home-grown technologies in North Carolina and creating more well-paying jobs.

Previous solicitations and listings of awardees under the Matching Funds program are available for download in the table below.

Fiscal Year Solicitation Award # Award $ Awardees
FY 2019  Solicitation Pending Pending Pending
No Funds
FY 2018
 N/A N/A  N/A N/A 
FY 2017 Solicitation 62 $3,686,680 Awardees
FY 2016 Solicitation 40 $1,954,004 Awardees
FY 2015 Solicitation 51 $2,500,000 Awardees
No Funds
FY 12-14
 N/A  N/A N/A N/A
FY 2011 Solicitation 44 $1,311,513 Awardees
FY 2010 Solicitation 22 $1,018,940 Awardees
FY 2009 Solicitation 54 $3,968,589 Awardees
FY 2008 Solicitation 49 $4,675,952 Awardees
FY 2007 Solicitation 51 $4,553,918 Awardees
FY 2006 Solicitation 25 $1,111,817 Awardees
Total   398 24,781,413 Awardees

Previous solicitations for the One NC Small Business Incentive Funds Program can be found below:

Program Impacts & Success Stories

Program Impacts & Success Stories

Program Impacts

In 2017, a detailed analysis of the One NC Small Business Matching Funds Program impacts was conducted. The evaluation found that, since its inception in 2006, the program has helped enable:

  • the creation and retention of nearly 900 private sector jobs statewide – more to come as more companies benefit and grow.
  • more than 250 small businesses bring to market biotechnology, nanotechnology, medical technologies, computer software, military/defense technologies, pharmaceuticals, textiles, and other high-tech applications.
  • more than 77 percent of the small businesses to remain in operation.
  • the small businesses to attract more than $515 million in external investment, including more than $122 million in follow-on federal funds.
  • 60 percent of NC matching grant winners have gone on to win Phase II federal grant awards, each with a considerably larger average value of $1 million (nationally, 54 percent of Phase I award winners graduate to Phase II awards).
  • the small businesses to produce more than $125 million in total sales resulting directly from the technology developed with Program funding.
  • significant technology/business-development partnerships among NC universities & businesses.

For a printable two-page summary of the strong impacts of the One NC Small Business Program since its inception in 2006, see One NC Small Business Program Fact Sheet (September 2018).

For an economic impact analysis of the overall impacts on North Carolina’s economy resulting from the increased number of employees that North Carolina small businesses created with the One NC Small Business Program grants between 2006 and 2018, see The Impact of the One NC Small Business Matching Grants Program on North Carolina’s Economy: Evidence from IMPLAN (May 2018).

Success Stories

  • Bennett Aerospace (Cary) - Smart Engineering Creates New Products & A Successful Company
  • Corvid Technologies (Mooresville) - One North Carolina Small Business Program Supports Engineering Firm's Overwhelming Growth
  • Prevention Strategies (Greensboro) - Preventing Bad Behavior Alone Doesn't Lead to Business Success
  • Precision BioSciences (Durham) - Cutting-Edge Leadership in a New Technology Can Cut Both Ways
  • Ribometrix (Durham) - Innovative Treatment Strategy for Human Disease Shapes a Successful Biotech Company
  • United Protective Technologies (Locust) - Thin Coatings Protect Military Investments and Facilitate Small Business Growth
  • Vigilant CyberSystems (Mt. Airy) - Surviving Threats in Cyberspace and The Tough World of Business
  • More stories coming soon.
Grantee Companies

Grantee Companies

0 Base Design, LLC
3-C Institute for Social Development, Inc.
3F, LLC
3TEX, Inc.
4pi Analysis, Inc.
A-B-Sea Research, Inc.
Adamas Nanotechnologies, Inc.
Adroit Materials, Inc.
Advanced Digital Systems, Inc.
Advanced Hydrogen Technologies Corporation
Advanced Liquid Logic, Inc.
Advanced TeleCare, LLC
Affinergy, LLC
Agile Sciences, Inc.
AI Tracking Solutions, LLC
Air Control Techniques, P.C.
Akoustis, Inc.
Alderon Biosciences, Inc. 
Alditri Technologies, Inc.
Algaen Corporation 
Allotropica Technologies, Inc.
Altis Biosystems, Inc.
Altometrics, Inc.
Ambient Logic, LLC
AP Solutions, Inc.
Appealing Products, Inc.
Applied LifeSciences & Systems, LLC
Applied Quantum Technologies, Inc.
Applied Science International, LLC
Arcato Laboratories, Inc.
Arctic, Inc.
ArrayXpress, Inc.
Arrevus, Inc.
Asklepios BioPharmaceutical, Inc.
Assist Equipment Development, Inc.
Athena's Compass, LLC
Auger Communications, Inc.
AURA Technologies, LLC
AxNano, LLC
b3 bio, Inc.
Baebies, Inc.
Bennett Aerospace, Inc.
Biofluidica, Inc.
Biographics, Inc.
BioKier, Inc.
BioLink Life Sciences, Inc. 
BioMarck Pharmaceutical, Ltd.
BioMedomics, Inc.
BioMojo, LLC
Bioptigen, Inc.
Black Velvet Solar, Inc.
Blue Ridge Research and Consulting, LLC
BotaniPharm, LLC
Brighton Development, LLC
Broad Digital, LLC
Camras Vision, Inc.
Capture Pharmaceutical, Inc.
Carolina Unmanned Vehicles, Inc.
CD Neural Technologies, Inc.
Cell Microsystems, Inc.
Celldom, Inc.
Cellf BIO, LLC
Chaperone Therapeutics, Inc.
Cirque Productions, LLC
CivaTech Oncology, Inc.
Clairvoyant Technology, LLC
Clinical Sensors, Inc
Clinical Tools, Inc.
Cloud Solutions, LLC
Cognosci, Inc.
Collaborations Pharmaceuticals, Inc.
Corvid Technologies, LLC
CP Diagnositics, Inc.
Creative Bioreactor Designs, Inc.
Creative Scientist, Inc.
CryoFacets, Inc. 
CTW Development Company, LLC
CURL BIO, LLC
Cytex Therapeutics, Inc.
Dignify Therapeutics, LLC
Dot Metrics Technologies, Inc.
Edison Agrosciences, Inc.
Element Genomics, Inc.
EncepHeal Therapeutics, Inc.
Endacea, Inc.
Enformia, Inc.
Eno River Labs, LLC
Eno River Technologies Co., LLC
Entertainment Science & Virtual Heroes Joint Venture, Inc.
Enzerna Biosciences, LLC
EpiCypher, Inc. 
Eppin Pharma, Inc.
Ercole Biotech, Inc.
Eyedesis Biosciences, LLC
Falcon Therapeutics, Inc.
Firebird Advanced Materials, Inc.
Foard Systems Design, Inc. 
Fokuslabs Behavioral Solutions, Inc.
Forthright Engineering, PLLC
Galaxy Diagnostics, Inc.
GEM Tox Consultants and Labs, Inc.
Geometric Data Analytics, Inc.
Gigabeam Acquisition Corporation
Goldfinch Sensor Technologies and Analytics, LLC
GrassRoots Biotechnology, Inc.
GreatWall Systems, Inc.
GridBridge, Inc.
GTCAllison, LLC
G-Zero Therapeutics, Inc
Haw River Mushrooms, LLC
Health Outcomes, Inc. 
HealthSpan Diagnostics, LLC
HepatoSys, Inc.
HERMES, LLC
Horizon Performance, LLC
Humacyte, Inc.
Identizyme Defense Technologies, Inc.
Impulsonic, Inc.
Inanovate, Inc.
Independent Living Resources, Inc.
Indexus Biomedical, LLC
IngateyGen, LLC
Initos Pharmaceuticals, LLC
InnAVasc Medical, Inc.
InnerOptic Technology, Inc.
InnovaTech, Inc.
Innovation Research and Training, Inc.
Insect Diet and Rearing Research, LLC
InsituTec, Inc.
Integrated Laboratory Systems, Inc.
Integrated Oncology Solutions, Inc.
Intelli-Products, Inc.
International Association of Virtual Organizations, Inc.
Isolere Bio, Inc.
Keona Health, Inc.
Kepley Biosystems, Inc.
KeraNetics, LLC
Kyma Technologies, Inc.
LaamScience, Inc.
Laser Biopsy, Inc.
LifeSciTech, LLC
Liquidia Technologies, Inc.
Lumedica, Inc.
LUMEOVA, LLC
Lupine Materials and Technology, Inc.
MAA Laboratories, Inc.
ManningRF, LLC
Materials Innovation Technologies, LLC
Maverick BioFuels, Inc.
Mercury Science, Inc.
Metalytics, LLC
Microgrid Labs, Inc.
Microphase Coatings, Inc.
Morphormics, Inc.
MoveableCode, Inc.
MRI Cardiac Services, Inc.
MRPath, Inc.
Mucommune, LLC
Multi3D, LLC
Mycosynthetix, Inc.
Nanodiagnostic Technology, LLC
Nanolytics, Inc.
NanoTechLabs, Inc.
NanoVector, Inc.
NCO Technologies, LLC
Nekton Research, LLC
Neuro10-9 Pharma, Inc.
New Jersey Microsystems, Inc.
NIRvana Pharmaceuticals, Inc.
NIRvana Sciences, Inc.
Nitronex Corporation
Nocturnal Product Development, LLC
Novan, Inc.
NovaTarg, Inc.
Nuvotronics, Inc.
Oncoscope, Inc.
OncoTAb, Inc.
OpSource, Inc.
Optopo, Inc.
Optosonics, Inc.
Orbit Energy, Inc.
Parion Sciences, Inc.
Path BioAnalytics, Inc.
Phase Bioscience, Inc.
PhotonTech, LLC
Physcient, Inc.
Piedmont Biofuels Industrial, Inc.
Plureon Corporation
Polarean, Inc.
Polyglot Systems, Inc.
Praetego, Inc.
Precision BioSciences, Inc.
Precision Human Biolaboratory Inc./Ridge Diagnostics
Premitec, Inc.
Prevention Strategies, LLC
PrimeNeuro, Inc.
Protochips, Inc.
Proventys, Inc.
Puratec, LLC
Qatch Technologies, LLC
Qualiber, Inc.
QuarTek Corporation
Redbud Labs, Inc.
Religent, Inc.
Rescindo Therapeutics, Inc.
Reveris Therapeutics, LLC
Ribometrix, Inc.
Rivis, Inc.
Roundtable Analytics, Inc.
rPath, Inc.
Science Learning Resources, Inc.
SciKon Innovation, Inc.
ScitoVation, LLC
Scribner Associates, Inc.
SeaTox Research, Inc.
Secmation, LLC
Semprius, Inc.
Signal Innovations Group, Inc.
Sindre Metals, Inc.
SinnovaTek, Inc.
Sirga Advanced Biopharma, Inc.
Solitronics, LLC
SonoVol, Inc.
Southeast TechInventures, Inc.
SoyMeds, Inc.
Stovall Life Science, Inc.
STRAD Corporation
Studio Hagler, LLC
Sun Dance Genetics, LLC
SureMilk, LLC
Symberix, Inc.
SYSTAP, LLC
Technical Designs, Inc.
TeleSage Research, Inc.
Tensive Controls, Inc.
The Sandbox Learning Company, Inc.
TheraLogics, Inc.
ThinkZone, LLC
Third Floor Materials, Inc.
Treadwell Corporation
Triad Interactive Media, Inc.
Triad Semiconductor, Inc.
Triangle BioSystems, Inc.
Triangle Biotechnology, Inc.
Triangle Polymer Technologies, Inc.
TriboFilm Research, Inc.
United Protective Technologies, LLC
USML, LLC
Vadum, Inc.
Valencell, Inc.
Vascular Biosciences, Inc.
Vascular Pharmaceuticals, Inc/
VeritasCNC, Inc.
Vesta Therapeutics, Inc.
Video Collaboratory, LLC
Vigilant Cyber Systems, Inc.
Virtual Reality Aids, Inc.
Vortant Technologies, LLC
Voxel Innovations, Inc.
Wasatch Photonics, Inc.
Wave Computation Technologies, Inc.
Windlift, LLC
X-In8 Biologicals Corporation
Xintek, Inc.
ZellComp, Inc.
Zenalux Biomedical, Inc.
Zen-Bio, Inc.
Zumatek, Inc.
Zymeron Corporation

Submit a Report / Edit an Application

Submit a Report / Edit an Application

Reports and Applicatios for the One North Carolina Small Business Program are managed through the CyberGrants Management System.

To submit reports or survey, or to edit an existing application, for the Program, you can access the CyberGrants Management System using the links below:

If you are ready to request a Stage 2 payment disbursement, contact the staff of the Board of Science, Technology & Innovation.

Legislative Reports

Legislative Reports

The Board of Science, Technology & Innovation provides annual reports on the One North Carolina Small Business Program to the North Carolina General Assembly, as required by North Carolina General Statute § 143B‑437.83.

Copies of these reports are publicly available through the links below: